BRPI0516754A - usos e derivados de benzoxazina e quinoxalina - Google Patents

usos e derivados de benzoxazina e quinoxalina

Info

Publication number
BRPI0516754A
BRPI0516754A BRPI0516754-0A BRPI0516754A BRPI0516754A BR PI0516754 A BRPI0516754 A BR PI0516754A BR PI0516754 A BRPI0516754 A BR PI0516754A BR PI0516754 A BRPI0516754 A BR PI0516754A
Authority
BR
Brazil
Prior art keywords
benzoxazine
quinoxaline
derivatives
preparation
medicament
Prior art date
Application number
BRPI0516754-0A
Other languages
English (en)
Inventor
Li Zhang
Steven Sethofer
Shu-Hai Zhao
Douglas William Bonhaus
Renee Sharon Martin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0516754A publication Critical patent/BRPI0516754A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

USOS E DERIVADOS DE BENZOXAZINA E QUINOXALINA. Compostos da fórmula 1: ou um sal farmaceuticamente aceitável, destes, em que k, m, n, p, q, X, Y, Z, Ar, R¹, R², R³ e R¬ 4¬ são como definidos aqui bem como métodos para a preparação destes, composições farmacêuticas contendo-os e o uso destes para a preparação de um medicamento.
BRPI0516754-0A 2004-09-30 2005-09-22 usos e derivados de benzoxazina e quinoxalina BRPI0516754A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61470504P 2004-09-30 2004-09-30
US63060804P 2004-11-24 2004-11-24
PCT/EP2005/010238 WO2006037481A1 (en) 2004-09-30 2005-09-22 Benzoxazine and quinoxaline derivatives and uses

Publications (1)

Publication Number Publication Date
BRPI0516754A true BRPI0516754A (pt) 2008-09-16

Family

ID=35385358

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516754-0A BRPI0516754A (pt) 2004-09-30 2005-09-22 usos e derivados de benzoxazina e quinoxalina

Country Status (17)

Country Link
EP (1) EP1797051B1 (pt)
JP (1) JP2008514662A (pt)
KR (1) KR100875041B1 (pt)
AR (1) AR051115A1 (pt)
AT (1) ATE477248T1 (pt)
AU (1) AU2005291541B2 (pt)
BR (1) BRPI0516754A (pt)
CA (1) CA2581921A1 (pt)
DE (1) DE602005022896D1 (pt)
IL (1) IL182304A0 (pt)
MX (1) MX2007003911A (pt)
MY (1) MY139409A (pt)
NO (1) NO20071616L (pt)
NZ (1) NZ553848A (pt)
RU (1) RU2382036C2 (pt)
TW (1) TW200626567A (pt)
WO (1) WO2006037481A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005026543D1 (de) * 2004-09-30 2011-04-07 Hoffmann La Roche Zusammensetzungen und verfahren zur behandlung kognitiver störungen
CL2007003044A1 (es) * 2006-10-24 2008-07-04 Wyeth Corp Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros.
BRPI0920520A2 (pt) * 2008-09-08 2015-12-22 Hoffmann La Roche benzoxazinas 5-subistituídas
AU2015286049B2 (en) * 2014-07-08 2018-03-01 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic derivatives and pharmaceutical applications thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224941B (pt) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
NZ512765A (en) * 1998-12-17 2003-10-31 Wyeth Corp 2,3,4,4A-tetrahydro-1H-pyrazino(1,2-A)quinoxalin- 5(6H)one derivatives being 5HT2C agonists
CN1561338A (zh) * 2001-10-04 2005-01-05 惠氏公司 作为5－羟基色胺－6配体的苯并二氢吡喃衍生物
CN100429206C (zh) * 2002-05-13 2008-10-29 弗·哈夫曼-拉罗切有限公司 作为5－ht6调节剂的苯并嗪衍生物及其用途
DE602005026543D1 (de) * 2004-09-30 2011-04-07 Hoffmann La Roche Zusammensetzungen und verfahren zur behandlung kognitiver störungen

Also Published As

Publication number Publication date
AR051115A1 (es) 2006-12-20
CA2581921A1 (en) 2006-04-13
RU2382036C2 (ru) 2010-02-20
MX2007003911A (es) 2007-05-21
KR20070047844A (ko) 2007-05-07
AU2005291541A1 (en) 2006-04-13
NZ553848A (en) 2010-01-29
EP1797051B1 (en) 2010-08-11
TW200626567A (en) 2006-08-01
IL182304A0 (en) 2007-07-24
ATE477248T1 (de) 2010-08-15
EP1797051A1 (en) 2007-06-20
MY139409A (en) 2009-09-30
NO20071616L (no) 2007-04-25
DE602005022896D1 (de) 2010-09-23
RU2007110479A (ru) 2008-11-10
WO2006037481A1 (en) 2006-04-13
KR100875041B1 (ko) 2008-12-19
JP2008514662A (ja) 2008-05-08
AU2005291541B2 (en) 2011-03-10

Similar Documents

Publication Publication Date Title
BRPI0511532A (pt) composto, uso do mesmo, composição farmacêutica, e, métodos para a terapia de distúrbios gastrointestinais funcionais e de sìndrome do intestino irritável em um animal de sangue quente, e para a preparação de um composto
UY30183A1 (es) Derivados de quinolina
BRPI0511504A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides
ECSP10010197A (es) Derivados de piridina y pirazina útiles en el tratamiento de trastornos de proliferación celular
BRPI0515860B8 (pt) derivados de tetralin e indano, seus usos, e composição farmacêutica
BRPI0607545A2 (pt) composto, uso de um composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
UY29781A1 (es) Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos
BRPI0720551A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo
MY144655A (en) Pyrimidine urea derivatives as kinase inhibitors
SE0402735D0 (sv) Novel compounds
UY27604A1 (es) Compuestos químicos.
DE60140814D1 (de) N-phenyl-2-pyrimidine-amine derivatives
BRPI0517792A (pt) macrolonas - quinolonas amino-substituìdas
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
NO20091893L (no) Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20085087L (no) Nye heterocykliske forbindelser
ATE499372T1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
NO20062491L (no) Benzoksazinderivter og deres anvendelse
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
BRPI0508485A (pt) compostos de pentafluorsulfanila, sua fabricação e uso como agentes farmacêuticos
TW200639156A (en) New compounds
BRPI0416853A (pt) pirazolila e imidazolila pirimidinas
BRPI0720742B8 (pt) derivados de heteroaril pirrolidinil e piperidinil cetona, seus usos e composição farmacêutica compreendo os mesmos
SE0302546D0 (sv) New compounds
BRPI0411246A (pt) composto, uso do mesmo, composição farmacêutica, e, métodos para terapia contra dor em um animal de sangue quente e para a preparação de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2168 DE 24/07/2012.